Indirubin is also a potent cyclin-dependent kinase inhibitor which is neuroprotective, attenuates high fat-high fructose induced Aβ-aggregation, and prevents tau-phosphorylation in Alzheimer’s disease animal models [54,55,56,57,58,59,60]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.